Abstract
Preimplantation genetic diagnosis (PGD) is publicly funded in New Zealand from 2006. PGD poses a range of issues that have ongoing significance for other later emerging applications of genetic technologies arising from the sequencing of the human genome. The idea of the ‘designer baby’ is the most publicly proclaimed outcome of new developments in genetic medicine.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
